12/06/2024
3:34 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:35 PM | Aileron Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:38 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:41 PM | Aileron Therapeutics (Issuer)
Aivado Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:03 PM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
4:17 PM | Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
| Form SCHEDULE 13G/A | |
08/22/2024
3:05 PM | Aileron Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/22/2024
3:06 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:06 PM | Aileron Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:07 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:09 PM | Aileron Therapeutics (Issuer)
Aivado Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
4:12 PM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
4:23 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:29 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
07/26/2024
3:33 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
07/26/2024
3:36 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
7:41 AM | Aileron Therapeutics (Filer)
| Form ARS | |
07/09/2024
7:30 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
07/09/2024
7:36 AM | Aileron Therapeutics (Filer)
| Form DEFA14A | |
06/17/2024
6:03 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
5:18 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:59 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
5:58 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:19 PM | Aileron Therapeutics (Issuer)
Cunningham Timothy M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/15/2024
4:16 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
4:54 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4/A | |
05/01/2024
6:15 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
4:24 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
4:25 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
4:16 PM | Aileron Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:40 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:54 AM | Aileron Therapeutics (Subject)
| Form FWP | |
04/30/2024
2:32 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2024
7:33 AM | Aileron Therapeutics (Filer)
| Form 10-K/A | |
04/16/2024
4:16 PM | Aileron Therapeutics (Subject)
Satter Muneer A (Filed by)
| Form SC 13D/A | |
04/15/2024
4:21 PM | Aileron Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
4:22 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:15 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4/A | |
04/10/2024
3:15 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4/A | |
04/02/2024
5:10 PM | Aileron Therapeutics (Issuer)
Garner Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
3:15 PM | Aileron Therapeutics (Filer)
| Form NT 10-K | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
03/29/2024
7:03 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:06 PM | Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:14 PM | Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
| Form SC 13G | |
03/01/2024
3:05 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:05 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
9:28 AM | Aileron Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
11:15 PM | Aileron Therapeutics (Filer)
| Form EFFECT | |
02/05/2024
12:20 PM | Aileron Therapeutics (Subject)
Kapnick Scott (Filed by)
| Form SC 13G/A | |
01/29/2024
7:46 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
01/29/2024
7:48 AM | Aileron Therapeutics (Filer)
| Form ARS | |
01/29/2024
7:14 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:44 PM | Aileron Therapeutics (Filer)
| Form PRE 14A | |
01/11/2024
3:18 PM | Aileron Therapeutics (Filer)
| Form 8-K/A | |
01/10/2024
3:08 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
